Efficacy of live attenuated porcine reproductive and respiratory syndrome virus 2 strains to protect pigs from challenge with a heterologous Vietnamese PRRSV 2 field strain

被引:2
|
作者
Sattler, Tatjana [1 ,2 ]
Pikalo, Jutta [1 ]
Wodak, Eveline [1 ]
Revilla-Fernandez, Sandra [1 ]
Steinrigl, Adi [1 ]
Bago, Zoltan [1 ]
Entenfellner, Ferdinand [3 ]
Claude, Jean-Baptiste [4 ]
Pez, Floriane [4 ]
Francillette, Maela [4 ]
Schmoll, Friedrich [1 ]
机构
[1] AGES, Inst Vet Dis Control, Robert Koch Gasse 17, A-2340 Modling, Austria
[2] Univ Leipzig, Clin Ruminants & Swine, Tierkliniken 11, D-04103 Leipzig, Germany
[3] Vet Practice Entenfellner, Bonnleiten 8, A-3073 Stossing, Austria
[4] BioSellal, Batiment Accinov,317 Ave Jean Jaures, F-69007 Lyon, France
关键词
HP PRRSV 2; Vaccine; Efficacy; Viral replication; Immune response; UNITED-STATES; VACCINE; PATHOGENICITY; CHINA; ANTIBODIES;
D O I
10.1186/s12917-018-1451-y
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Background: Effective vaccines against porcine reproductive and respiratory syndrome virus (PRRSV), especially against highly pathogenic (HP) PRRSV are still missing. The objective of this study was to evaluate the protective efficacy of an experimental live attenuated PRRSV 2 vaccine, composed of two strains, against heterologous challenge with a Vietnamese HP PRRSV 2 field strain. For this reason, 20 PRRSV negative piglets were divided into two groups. The pigs of group 1 were vaccinated with the experimental vaccine, group 2 remained unvaccinated. All study piglets received an intranasal challenge of the HP PRRSV 2 on day 0 of the study (42 days after vaccination). Blood samples were taken on days 7 and 21 after vaccination and on several days after challenge. On day 28 after challenge, all piglets were euthanized and pathologically examined. Results: On days 7 and 21 after vaccination, a PRRSV 2 viraemia was seen in all piglets of group 1 which remained detectable in seven piglets up to 42 days after vaccination. On day 3 after challenge, all piglets from both groups were positive in PRRSV 2 RT-qPCR. From day 7 onwards, viral load and number of PRRSV 2 positive pigs were lower in group 1 than in group 2. All pigs of group 1 seroconverted after PRRSV 2 vaccination. PRRSV antibodies were detected in serum of all study pigs from both groups from day 14 after challenge onwards. In group 2, moderate respiratory symptoms with occasional coughing were seen following the challenge with HP PRRSV 2. Pigs of group 1 remained clinically unaffected. Interstitial pneumonia was found in four piglets of group 1 and in all ten piglets of group 2. Histopathological findings were more severe in group 2. Conclusions: It was thus concluded that the used PRRSV 2 live experimental vaccine provided protection from clinical disease and marked reduction of histopathological findings and viral load in pigs challenged with a Vietnamese HP PRRSV 2 field strain.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Protection provided by a commercial modified-live porcine reproductive and respiratory syndrome virus (PRRSV) 1 vaccine (PRRSV1-MLV) against a Japanese PRRSV2 field strain
    Miranda, Joel
    Romero, Salvador
    de Lucas, Lidia
    Saito, Fumitoshi
    Fenech, Mar
    Diaz, Ivan
    JOURNAL OF VETERINARY SCIENCE, 2023, 24 (05)
  • [22] Efficacy evaluation of three modified-live virus vaccines against a strain of porcine reproductive and respiratory syndrome virus NADC30-like
    Zhou, Lei
    Yang, Beina
    Xu, Lei
    Jin, Huan
    Ge, Xinna
    Guo, Xin
    Han, Jun
    Yang, Hanchun
    VETERINARY MICROBIOLOGY, 2017, 207 : 108 - 116
  • [23] Evaluation of the Efficacy of an Attenuated Live Vaccine against Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus in Young Pigs
    Leng, Xue
    Li, Zhenguang
    Xia, Mingqi
    He, Yanliang
    Wu, Hua
    CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (08) : 1199 - 1206
  • [24] Dendritic cell-targeted porcine reproductive and respiratory syndrome virus (PRRSV) antigens adjuvanted with polyinosinic-polycytidylic acid (poly (I:C)) induced non-protective immune responses against heterologous type 2 PRRSV challenge in pigs
    Subramaniam, Sakthivel
    Pineyro, Pablo
    Derscheid, Rachel J.
    Madson, Darin M.
    Magstadt, Drew R.
    Meng, Xiang-Jin
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2017, 190 : 18 - 25
  • [25] Genetic and biological characterization of a Porcine Reproductive and Respiratory Syndrome Virus 2 (PRRSV-2) causing significant clinical disease in the field
    Kvisgaard, L. K.
    Larsen, L. E.
    Hjulsager, C. K.
    Botner, A.
    Rathkjen, P. H.
    Heegaard, P. M. H.
    Bisgaard, N. P.
    Nielsen, J.
    Hansen, M. S.
    VETERINARY MICROBIOLOGY, 2017, 211 : 74 - 83
  • [26] Comparative Effects of Vaccination against Porcine Circovirus Type 2 (PCV2) and Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) in a PCV2-PRRSV Challenge Model
    Park, Changhoon
    Oh, Yeonsu
    Seo, Hwi Won
    Han, Kiwon
    Chae, Chanhee
    CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (03) : 369 - 376
  • [27] Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs
    Linhares, Daniel C. L.
    Cano, Jean Paul
    Wetzell, Thomas
    Nerem, Joel
    Torremorell, Montserrat
    Dee, Scott A.
    VACCINE, 2012, 30 (02) : 407 - 413
  • [28] Porcine reproductive and respiratory syndrome virus neutralizing antibodies provide in vivo cross-protection to PRRSV1 and PRRSV2 viral challenge
    Robinson, Sally R.
    Rahe, Michael C.
    Gray, Diem K.
    Martins, Kyra V.
    Murtaugh, Michael P.
    VIRUS RESEARCH, 2018, 248 : 13 - 23
  • [29] Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts
    Jeong, Jiwoon
    Park, Changhoon
    Oh, Taehwan
    Park, Kee Hwan
    Yang, Siyeon
    Kang, Ikjae
    Park, Su-Jin
    Chae, Chanhee
    VETERINARY MICROBIOLOGY, 2018, 223 : 119 - 125
  • [30] Protective efficacy of a candidate live attenuated vaccine derived from the SD-R strain of lineage 1 porcine reproductive and respiratory syndrome virus against a lethal challenge with HP-PRRSV HuN4 in piglets
    Zhang, Hongliang
    Li, Chao
    Xu, Hu
    Gong, Bangjun
    Li, Wansheng
    Guo, Zhenyang
    Xiang, Lirun
    Sun, Qi
    Zhao, Jing
    Peng, Jinmei
    Wang, Qian
    Zhou, Guohui
    Tang, Yan-Dong
    An, Tongqing
    Cai, Xue-Hui
    Tian, Zhi-Jun
    MICROBIOLOGY SPECTRUM, 2023, 11 (06):